MEDIDATA

medidata.com · New York City, United States of America

Medidata, a Dassault Systèmes company, provides cloud-based software and data analytics solutions that support the design, planning, execution, and management of clinical trials for life sciences organizations. Its platform is used by pharmaceutical, biotechnology, medical device companies, and contract research organizations to collect, manage, and analyze clinical and real‑world data. Medidata generates revenue through subscription software licenses, data and analytics products, and related professional and support services.

  • Clinical Trial & Research Software
  • Data Warehousing & Lakes
  • Business Intelligence & Dashboards
Revenue
$1.2B
Employees
3,500
Founded
1999
Headquarters
New York City, United States of America

What 84 Arbolus experts think of MEDIDATA

NPS scores for Medidata are predominantly in the 7–10 range, indicating high satisfaction, with a strong concentration of 8s and 10s. Renewal intent is mostly positive, especially among high and mid spenders; some uncertainty is seen in lower spend brackets. Stickiness is high, with the majority at MoreThan1Year implementation. Expert feedback highlights robust clinical workflows and operational value, but notes configuration complexity and usability as recurring themes.Overall Customer Sentiment: Positive

Who reviewed MEDIDATA

Total customers 84 74 current · 10 former
Reviews growth +23 in six months
Seniority of respondents
  • C-Suite 52% (44)
  • Director 35% (29)
  • Manager 14% (12)
Finance Leader Director NPS 8
Strategy Leader C-Suite NPS 7 Not renewing
Revenue Partner Director NPS 8 Will renew

Employer names and spend open in the full report, along with the other 81 customers.

Everything 84 customers told us about MEDIDATA.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

25 Net Promoter Score, from 82 scored reviews
  • Promoters 30
  • Passives 43
  • Detractors 9

Cumulative NPS by month

+0 over 6 months
  • Mar 8
  • Apr 8
  • May 8
  • Jun 8
  • Jul 8
  • Sep 8

Net Promoter Score across 4 reviews, accumulated up to each month. Category median 26 across 4 companies.

Praised

  • Actionable Automation
  • AI-Enhanced Workflows
  • Usability Improvements
  • Continued Support and Expansion

Criticised

  • Competitive Operating Burden
  • Support and Commercial Deterioration
  • Opaque AI Automation Risk
  • Configuration Complexity

What customers say

Continued Support and Expansion
“We plan to renew and expand Medidata usage where there is proven demand, as we've seen tangible process improvements and support performance.”
Integration with Existing Systems
“The platform's broad ecosystem coverage and integration have enabled us to capture more data with less manual reconciliation and improved operational visibility.”
Mature and Scalable Workflows
“I would recommend Medidata for its mature clinical workflows and strong support for complex global studies, which deliver clear value and are critical to our operations.”

Renewal intent

Plan to renew 53%
  • Will renew 35
  • Undecided 24
  • Not renewing 7

Plan to renew, by seniority

  • C-Suite 53% 34 answers
  • Director 52% 23 answers
  • Manager 43% 7 answers
  • Not specified 100% 2 answers
  • 8.5/10 Average score from customers who will renew
  • 7.8/10 Average score from undecided customers
  • 6.1/10 Average score from customers not renewing

Top alternatives

Most weighed by MEDIDATA customers

Report

For people who use MEDIDATA

Do you use MEDIDATA at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 84 customers of MEDIDATA have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.